MARCELLI, LORENZO
 Distribuzione geografica
Continente #
AS - Asia 104
NA - Nord America 53
EU - Europa 31
SA - Sud America 18
AF - Africa 1
Totale 207
Nazione #
SG - Singapore 67
US - Stati Uniti d'America 51
BR - Brasile 17
HK - Hong Kong 16
CN - Cina 12
DE - Germania 10
IT - Italia 7
FI - Finlandia 6
VN - Vietnam 5
ID - Indonesia 3
CA - Canada 2
NL - Olanda 2
PL - Polonia 2
AT - Austria 1
CO - Colombia 1
FR - Francia 1
GB - Regno Unito 1
PK - Pakistan 1
RO - Romania 1
ZA - Sudafrica 1
Totale 207
Città #
Singapore 47
Hong Kong 15
Dallas 7
Munich 7
Beijing 5
Council Bluffs 4
The Dalles 4
Jakarta 3
Los Angeles 3
Salt Lake City 3
San Jose 3
Turku 3
Buffalo 2
Dongguan 2
Guiyang 2
Helsinki 2
Ho Chi Minh City 2
Lucca 2
Mascalucia 2
New York 2
Nuremberg 2
São Paulo 2
Aparecida de Goiânia 1
Atlanta 1
Boston 1
Brooklyn 1
Camaçari 1
Campinas 1
Constanța 1
Da Nang 1
Del Norte 1
Duque de Caxias 1
El Cerrito 1
Engelhard 1
Frankfurt am Main 1
Goiânia 1
Guaratuba 1
Haiphong 1
Hanoi 1
Houston 1
Ipatinga 1
Itajuípe 1
Itatiba 1
Jacareí 1
Johannesburg 1
Joinville 1
Lahore 1
Lappeenranta 1
Londrina 1
Ottawa 1
Palm Bay 1
Passo Fundo 1
Propriá 1
Rio de Janeiro 1
Santa Clara 1
St. George 1
Toronto 1
Warsaw 1
Totale 160
Nome #
Successful long‐term guselkumab treatment of severe plaque psoriasis in patients with class III obesity: A case series 76
Characterization of Super-Responder Profile in Chronic Plaque Psoriatic Patients under Guselkumab Treatment: A Long-Term Real-Life Experience 52
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS) 47
Deucravacitinib, a selective tyrosine kinase 2 inhibitor, for the treatment of moderate-to-severe plaque psoriasis 44
Totale 219
Categoria #
all - tutte 1.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202420 0 0 0 0 0 0 0 0 0 6 13 1
2024/202588 3 7 3 13 6 13 6 4 7 9 9 8
2025/2026111 18 12 24 6 41 3 7 0 0 0 0 0
Totale 219